Moreover, when considering the position of LOF variants within the gene, those mapped at the 5′-end of BRCA1, which lead to loss of all functional protein domains, showed a higher BC risk compared to LOF variants located downstream. This evidence concerns the gene BRCA1 and breast cancer.